Related references
Note: Only part of the references are listed.Short-term Intraocular Pressure Changes Immediately After Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents
Judy E. Kim et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Vascular endothelial growth factor in eye disease
J. S. Penn et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2008)
Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial
Hamid Ahmadieh et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2008)
Primary intravitreal bevacizumab for the management of pseudophakic cystoid macular edema - Pilot study of the Pan-American Collaborative Retina Study Group
J. Fernando Arevalo et al.
JOURNAL OF CATARACT AND REFRACTIVE SURGERY (2007)
Inflammatory cystoid macular edema
Aniki Rothova
CURRENT OPINION IN OPHTHALMOLOGY (2007)
In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac
Tom Walters et al.
JOURNAL OF CATARACT AND REFRACTIVE SURGERY (2007)
Clinical pseudophakic cystoid macular edema - Risk factors for development and duration after treatment
Bonnie A. Henderson et al.
JOURNAL OF CATARACT AND REFRACTIVE SURGERY (2007)
Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology
Timothy S. Kern et al.
DIABETES (2007)
Intravitreal steroids in the management of macular oedema
Sobha Sivaprasad et al.
ACTA OPHTHALMOLOGICA SCANDINAVICA (2006)
Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown
JL Edelman et al.
EXPERIMENTAL EYE RESEARCH (2005)
Inflammation-mediated retinal edema in the rabbit is inhibited by topical nepafenac
MA Kapin et al.
INFLAMMATION (2003)
Studies on the mechanism of action of anti-inflammatory drugs - A paper in honour of John Vane
RJ Flower
THROMBOSIS RESEARCH (2003)
Topical nepafenac inhibits ocular neovascularization
K Takahashi et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
A controlled study of vitrectomy for diabetic macular edema
T Otani et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2002)
Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers
TL Ke et al.
INFLAMMATION (2000)
Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy
DA Gamache et al.
INFLAMMATION (2000)
Share Paper
